Counselors in Littlerock, CA Accepting Medicare
3 Counselors found. Showing 1 - 3
 Mr. Kurt Anthony Muniz Ii Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 8730 E Avenue T4, Littlerock, CA 93543 Phone: 949-205-8167 |
 Laura Ann Lien Mitobe, MA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11108 East Ave. V 8, Littlerock, CA 93543 Phone: 661-433-4385 |
Audrea Jeanne Pena Brown, RADTI Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 37540 97th St E, Littlerock, CA 93543 Phone: 661-234-2110 |
News Archive
AVAT, Africa CDC and COVAX release statement regarding donations of COVID-19 vaccines to Africa
Building on lessons learned from our collective experience with dose donations over the past several months, the African Vaccine Acquisition Trust, the Africa Centres for Disease Control and Prevention and COVAX wish to draw the attention of the international community to the situation of donations of COVID-19 vaccines to Africa, and other COVAX participating economies, particularly those supported by the Gavi COVAX Advance Market Commitment.
Naurex receives new U.S. patent for its lead compound, GLYX-13
Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced issuance of a new U.S. patent for its lead compound, GLYX-13.
NIH awards Novavax a SBIR grant for respiratory syncytial virus vaccine research
Novavax, Inc. announced today that it has received a Small Business and Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The grant from the NIAID is to support a segment of the Company's preclinical research program for the respiratory syncytial virus (RSV) particle-based vaccine.
The Sports Club's operating revenues for fourth-quarter 2009 decrease by 16.3%
The Sports Club Company, Inc. today announced financial results for the fourth quarter and year ended December 31, 2009.
QPS acquires Xendo Drug Development
QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the completion of its acquisition of Xendo Drug Development BV (XDD), headquartered in Groningen, The Netherlands. XDD, a European contract research organization (CRO), will be known as QPS Netherlands BV and become a wholly-owned subsidiary of QPS Holdings, LLC.
› Verified 7 days ago